Johnson & Johnson – Resilience Dashboard

In 2023, Johnson & Johnson improved end-to-end visibility into vulnerabilities across the company’s critical product portfolio with the introduction of a Resilience Dashboard.

In near real-time, the Dashboard systematically and dynamically analyzes a multitude of risks across the value chain to uncover and elevate new risk insights that in isolation may not be seen, and then executes an optimal response.

The Dashboard’s data allows J&J to elevate supply chain resilience into the strategic decision-making process and deliver confident, quantifiable decisions that reduce disruptions, drive growth and build trust with patients and customers.

In 2023, the Dashboard was deployed across all critical products in our Innovative Medicine supply chain and is being continually improved to support resilience in new product introductions and products across all stages of their lifecycle.